US Physical Therapy/$USPH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About US Physical Therapy
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
- Ticker
- $USPH
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 6,374
- Headquarters
- Houston, United States
- Website
- www.usph.com
USPH Metrics
BasicAdvanced
$1.3B
488.89
$0.18
1.13
$1.83
2.14%
Price and volume
Market cap
$1.3B
Beta
1.13
52-week high
$90.94
52-week low
$58.19
Average daily volume
165K
Dividend rate
$1.83
Financial strength
Current ratio
1.271
Quick ratio
1.12
Long term debt to equity
0.441
Total debt to equity
0.503
Dividend payout ratio (TTM)
85.50%
Interest coverage (TTM)
7.40%
Profitability
EBITDA (TTM)
102.009
Gross margin (TTM)
21.47%
Net profit margin (TTM)
4.01%
Operating margin (TTM)
9.90%
Effective tax rate (TTM)
26.06%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
4.10%
Return on equity (TTM)
6.51%
Valuation
Price to earnings (TTM)
488.893
Price to revenue (TTM)
1.617
Price to book
2.85
Price to tangible book (TTM)
-2.88
Price to free cash flow (TTM)
20.297
Free cash flow yield (TTM)
4.93%
Free cash flow per share (TTM)
4.229
Dividend yield (TTM)
2.13%
Forward dividend yield
2.14%
Growth
Revenue change (TTM)
11.36%
Earnings per share change (TTM)
-92.32%
3-year revenue growth (CAGR)
11.83%
10-year revenue growth (CAGR)
8.87%
3-year earnings per share growth (CAGR)
-55.03%
10-year earnings per share growth (CAGR)
-20.22%
3-year dividend per share growth (CAGR)
2.70%
10-year dividend per share growth (CAGR)
11.02%
What the Analysts think about USPH
Analyst ratings (Buy, Hold, Sell) for US Physical Therapy stock.
Analyst projections of the future price of US Physical Therapy stock.
Bulls say / Bears say
Q2 revenue rose 8.5%, with patient visits up 6.6% and revenue per visit up 2.1% to $107.59. Average daily visits per clinic reached a record, showing stronger traffic and pricing in the core business. (SEC)
Hospital partnerships could add a further growth leg as they move from set-up to full operation: 31 clinics had been integrated by quarter-end, with another 39 due to transition in Q3. The initial rollout contributed $5.6 million of Q2 revenue, and management expects the affiliations to support growth in the second half. (The Motley Fool)
USPH is expanding through acquisitions, with three 2026 deals representing about $27 million of annualised revenue for a combined purchase price of $37.6 million. The latest 12-clinic practice adds a new state and about $12 million in annual revenue. (Nasdaq, U.S. Physical Therapy)
Revenue growth has not yet translated into stronger reported earnings: Q2 net income attributable to USPH shareholders fell to $9.9 million from $12.4 million a year earlier. Physical therapy margin also narrowed year on year, leaving the quality of growth a concern. (SEC)
Unusually high employee medical claims and costs to staff hospital-affiliation launches are weighing on margins. Management put the year-to-date claims-related cost swing at about $3.2 million, while adjusted salaries and related costs rose to 57.5% of Q2 revenue from 56.4%. (The Motley Fool)
Reimbursement remains exposed to payer decisions: a policy change by a large Michigan payer reduced USPH’s net rate by about $0.30 per visit in Q2. That illustrates how insurer terms can offset gains in visit volumes and rates elsewhere. (Yahoo Finance)
Data summarised monthly by Lightyear AI. Last updated on 17 Oct 2026.
USPH Financial Performance
Revenues and expenses
USPH Earnings Performance
Company profitability
Upcoming events
No upcoming events
USPH News
AllArticlesVideos
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
Business Wire1 month ago
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
MarketBeat2 months ago
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
Business Wire2 months ago
Funds containing USPH
Fund name | Fund size | $USPH weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.07% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.07% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.04% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.04% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.